Publications
MAP present at major conferences such as ISPOR as well as publishing our own view points on particularly hot topics. See our publications, presentations and papers here with many more presentations available within our website.
ISPOR 2018 - Barcelona: Do Early Access schemes in the UK increase the likelihood of reimbursement and patient access?
Info
Download
ISPOR 2018 - Barcelona: A review of the NICE medical technologies evaluation programme for assessing medical devices and diagnostics in the UK
Info
Download
ISPOR 2018 - Barcelona: The impact of international reference pricing in Europe
Info
Download
ISPOR 2018 - Barcelona: Is patient access affected by the use of carer disutility in NICE highly specialised technology submissions?
Info
Download
ISPOR 2018 - Barcelona: Does reimbursement through the cancer drugs fund impact patient access in the UK?
Info
Download
ISPOR 2018 - Barcelona: Bridging the gap: Ensuring fair assessment of orphan treatments by health technology assessments in England
Info
Download
ISPOR 2018 - Barcelona: An examination of HTA outcomes where a patient access scheme or managed access agreement was used
Info
Download
ISPOR 2017 - Glasgow: Patient Access Schemes (PAS)
Info
Download
ISPOR 2017 - Glasgow: Orphan Products in England
Info
Download
ISPOR 2017 - Glasgow: HTA Launch Sequence - UK & I
Info
Download
ISPOR 2017 - Glasgow: Uptake of Ultra Rare Diseases: Ataluren Case Study
Info
Download
ISPOR 2017 - Glasgow: Managed Access Agreements (MAAs)
Info
Download
ISPOR 2017 - Glasgow: Generic Cancer Medicines
Info
Download
ISPOR 2017 - Glasgow: Sustainability and Transformation Partnerships (STPs)
Info
Download
ISPOR 2017 - Glasgow: MedTech Innovation Briefings (MIBs)
Info
Download
The consequences of Brexit in Spain - a life sciences perspective
Info
Download
ISPOR 2016 - Vienna: Review of Health Technology Assessment Requirements for Rare Diseases Across European Countries
Info
Download
ISPOR 2016 - Vienna: Review of the Recommendation made by NICE and SMC Relating to Treatments for Rare Diseases
Info
Download
ISPOR 2016 - Vienna: Review of National Policies for Rare Diseases Across EU Countries
Info
Download
ISPOR 2016 - Vienna: Predicting Orphan Designation and Marketing Authorisation Based on a Review of the European Medicines Agency Orphan Disease Register
Info
Download
ISPOR 2016 - Vienna: A Systematic Literature Review of Health Economics Evaluations of Treatments for Rare Diseases
Info
Download
ISPOR 2015 - Milan: The UK Pharmaceutical Price Regulation Scheme (PPRS)
Info
Download
EU and US Pricing and Reimbursement for Innovative Medicines
Info
Download
Enforceability of NICE Guidance and Guidelines
Info
Download
ISPOR 2015 - Philadelphia: NICE topic selection
Info
Download
ISPOR 2015 - Philadelphia: G-BA trend analysis in Germany
Info
Download
Ispor 2015 - Philadelphia: Implementation of NICE Guidelines
Info
Download
Ispor 2015 - Philadelphia: HTA trends in the UK and Germany
Info
Download
Ispor 2015 - Philadelphia: Cost minimization is an option in HTA submissions
Info
Download
Ispor 2015 - Philadelphia: SME preparedness for market entry
Info
Download
Ispor 2015 - Philadelphia: NICE technology appraisals – Trends
Info
Download
Ispor 2015 - Philadelphia: EU flat pricing and transparency rules
Info
Download
Ispor 2015 - Philadelphia: SMC decisions – Trends
Info
Download
Ispor 2015 - Philadelphia: SMC changes and access to Orphans
Info
Download
Connectivity in the Life Sciences and Healthcare Sectors: Fast-tracking BioPharma innovation to patients in Europe
Info
Download
The UK Pharmaceutical Price Regulation Scheme (PPRS) and the Statutory Regulations
Info
Download
Estimated cost and payment by results tariff reimbursement for idiopathic pulmonary fibrosis services across 14 specialist providers in England
Info
Download
